PHAT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Phathom Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 5.915 USD 3.05%

Market Cap: $480.8m

	Phathom Pharmaceuticals Inc NASDAQ:PHAT	US
C	Capita PLC OTC:CTAGF	UK
	Zhejiang Nhu Co Ltd SZSE:002001	CN
	LVMH Moet Hennessy Louis Vuitton SE PAR:MC	FR
	Tesla Inc NASDAQ:TSLA	US
F	Fujifilm Holdings Corp F:FJI	JP
	Amadeus IT Group SA F:AI3A	ES
L	La-Z-Boy Inc F:LAZ	US
Y	Yes 24 Co Ltd KOSDAQ:053280	KR
	Uni-Charm Indonesia Tbk PT IDX:UCID	ID
	Cleveland-Cliffs Inc NYSE:CLF	US
	Airports of Thailand PCL SET:AOT	TH
V	Vessel Co Ltd KOSDAQ:177350	KR

Profitability Summary

Phathom Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

83%

Strong 3Y Average Gross Margin

83%

Negative Operating Margin

-17%

Negative 3Y Average Operating Margin

-3,414%

Negative Net Margin

-41%

Negative 3Y Average Net Margin

-4,100%

Negative Free Cash Flow Margin

-15%

Negative 3Y Average Free Cash Flow Margin

-2,856%

Exceptional ROE

26%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-645%

ROIC is Increasing

-1,859% > -35%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.